Welcome to LookChem.com Sign In|Join Free
  • or
3-Chloro-6-iodopyridazine is an organic compound characterized by the presence of a pyridazine ring with a chlorine atom at the 3rd position and an iodine atom at the 6th position. It is a versatile intermediate in the synthesis of various chemical compounds and has potential applications in different industries due to its unique structural properties.

135034-10-5

Post Buying Request

135034-10-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

135034-10-5 Usage

Uses

Used in Pharmaceutical Industry:
3-Chloro-6-iodopyridazine is used as a reactant in the Suzuki-Miyaura coupling reaction for the synthesis of complex organic molecules, particularly in the development of new pharmaceutical compounds. The Suzuki-Miyaura coupling is a widely used method for the formation of carbon-carbon bonds, which is essential in the creation of diverse molecular structures with potential therapeutic applications.
Used in Chemical Synthesis:
3-Chloro-6-iodopyridazine is used as a reactant in the synthesis of 6-Chloropyridazine-3-carbonitrile (C368635), which is an important intermediate in the production of various chemical compounds. The carbonitrile group in 6-Chloropyridazine-3-carbonitrile can be further functionalized or used as a building block for the development of new molecules with specific properties and applications.

Check Digit Verification of cas no

The CAS Registry Mumber 135034-10-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,0,3 and 4 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 135034-10:
(8*1)+(7*3)+(6*5)+(5*0)+(4*3)+(3*4)+(2*1)+(1*0)=85
85 % 10 = 5
So 135034-10-5 is a valid CAS Registry Number.
InChI:InChI=1/C4H2ClIN2/c5-3-1-2-4(6)8-7-3/h1-2H

135034-10-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H63879)  3-Chloro-6-iodopyridazine, 97%   

  • 135034-10-5

  • 1g

  • 401.0CNY

  • Detail
  • Alfa Aesar

  • (H63879)  3-Chloro-6-iodopyridazine, 97%   

  • 135034-10-5

  • 5g

  • 1605.0CNY

  • Detail

135034-10-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Chloro-6-iodopyridazine

1.2 Other means of identification

Product number -
Other names 6-chloro-3-iodopyridazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:135034-10-5 SDS

135034-10-5Relevant academic research and scientific papers

Desymmetrization of dichloroazaheterocycles

Goodman, Allan J.,Stanforth, Stephen P.,Tarbit, Brian

, p. 15067 - 15070 (1999)

3,6-Dichloropyridizine 1a was converted in good yield into its mono-iodo derivative 1b when treated with a mixture of hydriodic acid and sodium iodide. Pure samples of the mono-iodo derivatives 2b, 3b and 4b could not be obtained from their corresponding dichlorinated precursors with these reagents. Compounds 1b and 4b underwent palladium catalysed Suzuki, Sonogashira and other coupling reactions.

Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB2 agonists for the treatment of inflammatory pain

Gleave, Robert J.,Beswick, Paul J.,Brown, Andrew J.,Giblin, Gerard M.P.,Goldsmith, Paul,Haslam, Carl P.,Mitchell, William L.,Nicholson, Neville H.,Page, Lee W.,Patel, Sadhana,Roomans, Susan,Slingsby, Brian P.,Swarbrick, Martin E.

, p. 465 - 468 (2010)

A series of 3-amino-6-aryl-pyridazines have been identified as CB2 agonists with high efficacy and selectivity against the CB1 receptor. Details of the investigation of structure-activity relationships (SAR) are disclosed, which led to the identification of pyridazine analogue 35, a compound with high potency in an in vivo model of inflammatory pain.

COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS

-

Paragraph 1849-1851, (2021/08/06)

Provided herein is a compound of formula (XXXII) or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer thereof or a physiologically functional derivative thereof, wherein R1, R2, R3, G, A, E, n, p, and q are defined herein. Also provided herein are compositions comprising a compound of formula (XXXII), and methods of using a compound of formula (XXXII), e.g., in the treatment or prevention of skin disorders.

PESTICIDALLY ACTIVE TETRACYCLIC HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS

-

Page/Page column 55, (2016/05/24)

Compounds of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides and can be prepared in a manner known per se.

PESTICIDALLY ACTIVE POLYCYCLIC DERIVATIVES WITH SULFUR SUBSTITUTED FIVE-MEMBERED RING HETEROCYLES

-

Page/Page column 85, (2016/11/14)

Polycyclic derivatives of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides and can be prepared in a manner known per se.

PESTICIDALLY ACTIVE POLYCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS

-

Page/Page column 89, (2016/12/22)

Polycyclic derivatives of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides and can be prepared in a manner known per se.

NOVEL TRIFLUOROMETHYL-OXADIAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

-

Page/Page column 68, (2013/06/27)

The invention relates to novel trifluoromethyl-oxadiazole derivatives of formula (I), and pharmaceutically acceptable salts thereof, in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, pharmaceutical com

THERAPEUTIC COMPOUNDS

-

Page/Page column 41, (2011/07/09)

The invention provides compounds of formula I or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for prepa

Heteroatom-substituted analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-adamantyl)-4- hydroxyphenyl]-3-chlorocinnamic acid

Xia, Zebin,Farhana, Lulu,Correa, Ricardo G.,Das, Jayanta K.,Castro, David J.,Yu, Jinghua,Oshima, Robert G.,Reed, John C.,Fontana, Joseph A.,Dawson, Marcia I.

experimental part, p. 3793 - 3816 (2011/08/06)

(E)-4-[3'-(1-Adamantyl)-4'-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC) induces the cell cycle arrest and apoptosis of cancer cells. Because its pharmacologic properties-solubility, bioavailability, and toxicity-required improvement for translation, s

3-(3-PYRIMIDIN-2-YLBENZYL)-1,2,4-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES AS MET KINASE INHIBITORS

-

Page/Page column 19, (2011/05/03)

Compounds of the formula (I), in which R1, R2, R3, R3′, R4 have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment of tumours.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 135034-10-5